A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam
DiabCare Asia
2 other identifiers
observational
1,631
1 country
1
Brief Summary
This study is conducted in Asia. The aim of this non-interventional study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in Vietnam.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2014
CompletedFirst Posted
Study publicly available on registry
February 20, 2014
CompletedStudy Start
First participant enrolled
April 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2015
CompletedOctober 23, 2019
October 1, 2019
4 months
February 13, 2014
October 21, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients having HbA1c ((Glycosylated Haemoglobin) as measured during survey) less than 7%
Evaluated at the first visit (only one study visit)
Secondary Outcomes (9)
Mean Fasting Plasma Glucose (FPG) of patients
Evaluated at the first visit (only one study visit)
Mean Postprandial Plasma Glucose (PPG) of patients
Evaluated at the first visit (only one study visit)
Mean HbA1c of patients
Evaluated at the first visit (only one study visit)
Proportion of patients having dyslipidemia
Evaluated at the first visit (only one study visit)
Proportion of patients having hypertension
Evaluated at the first visit (only one study visit)
- +4 more secondary outcomes
Study Arms (1)
Subjects with diabetes mellitus (type 2)
Interventions
Patients will fill out a questionnaire by interview.
Eligibility Criteria
People having been treated for at least a year are eligible for the study. The selection of the patients will be done randomly by the individual physician involved in the study.
You may qualify if:
- People with type 2 diabetes mellitus (DM) who are being treated, with any of the non-pharmacological or pharmacological options, at a particular centre for at least 1 year and who have visited the centre within the last 3-6 months
- Patients willing to sign informed consent form
You may not qualify if:
- Previous participation in this study
- Unable to comply with protocol requirements
- Confirmed or suspected pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novo Nordisk A/Slead
Study Sites (1)
Novo Nordisk Investigational Site
Hanoi, Vietnam
Related Publications (1)
Nguyen KT, Diep BTT, Nguyen VKD, Lam HV, Tran KQ, Tran NQ. A cross-sectional study to evaluate diabetes management, control and complications in 1631 patients with type 2 diabetes mellitus in Vietnam (DiabCare Asia). Int J Diabetes Dev Ctries 2019 [Epub ahead of print] DOI: 10.1007/s13410-019-00755-w
RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2014
First Posted
February 20, 2014
Study Start
April 22, 2015
Primary Completion
August 31, 2015
Study Completion
August 31, 2015
Last Updated
October 23, 2019
Record last verified: 2019-10